EXFORGE HCT 5 mg/160 mg/25 mg, comprimé pelliculé

Business Listing - September 04, 2021

EXFORGE HCT 5 mg/160 mg/25 mg, comprimé pelliculé

EXFORGE HCT 5 mg/160 mg/25 mg, comprimé pelliculé comprimé pelliculé orale Autorisation active Procédure centralisée Commercialisée 10/16/2009 NOVARTIS EUROPHARM (IRLANDE)

Tags & Categories

active comprimé autorisation procédure commercialisée orale pelliculé novartis centralisée exforge

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business